https://www.selleckchem.com/
89days reduction in LOS compared with patients treated with standard care (95% CI - 1.70 to - 0.07days, p = 0.03). There was no statistically significant difference in readmission rate (OR 1.00, 95% CI 0.53 to 1.87, p = 1.0 or SSI/SSO (OR 1.19, 95% CI 0.67 to 2.11, p = 0.56) between groups. The use of ERAS in patients undergoing AWR was found to significantly reduce LOS without increasing the readmission rate or SSI/SSO. Based on the existing literature, ERAS protocols should be implemented for patients undergoing AWR. The use of ERAS in patients undergoi
Curtir
Comentario
Compartilhar
